1
Only Abbott enables you to detect and quantitate all known groups and subtypes. A recent study by the Centers for Disease Control and Prevention involving more than 3,000 HIV patients in the United States found that 5.1 percent of those patients were infected with HIV-1 non-B subtypes. 1 Looking Closer As more HIV-1 non-B subtypes come into the picture today, recognizing them is critical to care. Now you can, with the increased sensitivity and consistency of Abbott’s new FDA-approved RealTime HIV-1 Viral Load Test. • Detect and quantitate all known HIV-1 groups M, N, and 0 as well as non-B subtypes 2 • Benefit from unsurpassed sensitivity of 40 copies/mL, with 100% specificity 2 • Rely on excellent correlation (rebaselining not required) with current HIV-1 viral load tests (correlation coefficient, 0.936) 2 • Count on consistent results, from test to test and lab to lab Seeing Farther When you know more, you can do more. Unparalleled sensitivity of 40 copies/mL enables you to effectively monitor viral load levels and detect inadequate viral suppression earlier. The added confidence Abbott’s RealTime HIV-1 Viral Load test brings is vital when you’re faced with yet another treatment decision. 1. Abstract of the 14th Conference on Retroviruses and Opportunistic Infections, Mahle K, Bodnar U, et al., 2007. 2. Abbott RealTime HIV-1 package insert REF 6L18 #51-602146/R2. RESULTS. They’re the reason we work so hard. HIV-1 is changing. Now your ability to stay ahead of it is changing, too. Ask for Abbott RealTi me HIV-1today. Call 1-800-553-7042 or go to www.abbottmolecular.com Intended Use: The Abbott RealTime HIV-1 Assay is an in vitro reverse transcription-polymerase chain reaction (RT-PCR) assay for the quantitation of Human Immunodeficiency Virus type 1 (HIV-1) on the automated m2000 System in human plasma from HIV-1 infected individuals over the range of 40 to 10,000,000 copies/mL. The Abbott RealTime HIV-1 Assay is intended for use in conjunction with clinical presentation and other laboratory markers for disease prognosis and for use as an aid in assessing viral response to antiretroviral treatment as measured by changes in plasma HIV-1 RNA levels. This assay is not intended to be used as a donor screening test for HIV-1 or as a diagnostic test to confirm the presence of HIV-1 infection. © 2007 Abbott Laboratories Recognize every known HIV-1 group and subtype now. Introducing Abbott’s RealTi me HIV-1 Viral Load Test Beyond B: The Changing Face of HIV-1

Changing Face Ad

Embed Size (px)

DESCRIPTION

Abbott Labs "Changing Faces" National Ad Campaign.

Citation preview

Page 1: Changing Face Ad

Only Abbott enables you to detect and quantitate all known groups and subtypes.A recent study by the Centers for Disease Control and Prevention involving more than3,000 HIV patients in the United States found that 5.1 percent of those patients wereinfected with HIV-1 non-B subtypes.1

Looking CloserAs more HIV-1 non-B subtypes come into the picture today, recognizing them is criticalto care. Now you can, with the increased sensitivity and consistency of Abbott’s newFDA-approved RealTime HIV-1 Viral Load Test.

• Detect and quantitate all known HIV-1 groups M, N, and 0as well as non-B subtypes2

• Benefit from unsurpassed sensitivity of 40 copies/mL,with 100% specificity2

• Rely on excellent correlation (rebaselining not required) withcurrent HIV-1 viral load tests (correlation coefficient, 0.936)2

• Count on consistent results, from test to test and lab to lab

Seeing FartherWhen you know more, you can do more.

Unparalleled sensitivity of 40 copies/mL enables you to effectively monitor viral loadlevels and detect inadequate viral suppression earlier. The added confidence Abbott’sRealTime HIV-1 Viral Load test brings is vital when you’re faced with yet anothertreatment decision.

1. Abstract of the 14th Conference on Retroviruses and Opportunistic Infections, Mahle K, Bodnar U, et al., 2007.2. Abbott RealTime HIV-1 package insert REF 6L18 #51-602146/R2.

RESULTS. They’re the reason we work so hard.

HIV-1 is changing.Now your ability to stay ahead of it is changing, too.

Ask for Abbott RealTime HIV-1 today.

Call 1-800-553-7042 or go to www.abbottmolecular.com

Intended Use: The Abbott RealTime HIV-1 Assay is an in vitro reverse transcription-polymerase chain reaction (RT-PCR) assay for thequantitation of Human Immunodeficiency Virus type 1 (HIV-1) on the automated m2000 System in human plasma from HIV-1 infectedindividuals over the range of 40 to 10,000,000 copies/mL. The Abbott RealTime HIV-1 Assay is intended for use in conjunction withclinical presentation and other laboratory markers for disease prognosis and for use as an aid in assessing viral response to antiretroviraltreatment as measured by changes in plasma HIV-1 RNA levels. This assay is not intended to be used as a donor screening test forHIV-1 or as a diagnostic test to confirm the presence of HIV-1 infection.

© 2007 Abbott Laboratories

Recognize every known HIV-1 group and subtype now.

Introducing Abbott’s RealTime HIV-1 Viral Load Test

Beyond B:The Changing Face of HIV-1

AMU7-011_Changing Face Mom & Baby JMD Ad:Layout 1 12/10/08 8:33 AM Page 1